Chart, page-20824

There is every chance of the price falling further with 12.5c the only real reference point of potential ta support for now. Add BRNs reluctance to announce anything to its primarily listed exchange, the ASX which bodes poorly also for further drops in valuation. Any low price is still on the cards here unfortunately for already bleeding shareholders. It continually astounds me that there is not more effort from BRN management put into alignment with ASX obligations and expectations from shareholders, versus what the "social media" and "company website" narratives tell.

The bottom line is that short selling is feasting on the above situation, and is still currently still well in control of the devaluing of the company. I honestly didn't think it would get this bad in terms of low valuation.